Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Insija Selene"'
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
5-fluorouracil (5FU) and capecitabine are fluoropyrimidine anti-neoplastic drugs commonly used in the treatment of different types of cancer. Hereditary dihydropyrimdine deaminase (DPD), thymidylate synthase mutations and drug overdose may lead to li
Externí odkaz:
https://doaj.org/article/2d586d8a4d184adc87f539cd753b5eb9
Autor:
Asim Kichloo MD, Michael Stanley Albosta MD, Shakeel M. Jamal MD, Michael Aljadah MD, Farah Wani MD, Insija Selene MD, Jagmeet Singh MD, Asma Taj MD
Publikováno v:
Journal of Investigative Medicine High Impact Case Reports, Vol 8 (2020)
Immune checkpoint inhibitors are rapidly becoming popular therapeutic options for patients suffering from a number of malignancies. Atezolizumab is a programmed cell death ligand-1 inhibitor, and binding to this ligand decreases the ability of tumor
Externí odkaz:
https://doaj.org/article/4ee26dea6fea49c7b59bd017a0fb0148
Autor:
Valamparampil, Mathew Joseph, Mohan, Ananth, Jose, Chinu, Sadheesan, Deepthi Kottassery, Aby, Jemin Jose, Vasudevakaimal, Prasannakumar, Varghese, Sara, Surendrannair, Anish Tekkumkara, Ashokan, Achu Laila, Madhusoodhanan, Resmi Santhakumari, Ilyas, Insija Selene, Rajeevan, Amjith, Karthikeyan, Sreekanth Balakrishnan, Devadhas, Krishna Sulochana, Raghunath, Rajesh, Surendran, Sethulekshmi, Muraleedharanpillai, Harikrishnan, Nujum, Zinia Thajudeen
Publikováno v:
Asia Pacific Journal of Public Health, 2018 May 01. 30(4), 351-360.
Externí odkaz:
https://www.jstor.org/stable/27009112
Publikováno v:
Annals of Internal Medicine: Clinical Cases. 2
Autor:
Jemin Jose Aby, Prasannakumar Vasudevakaimal, Sethulekshmi Surendran, Deepthi Kottassery Sadheesan, Insija Selene Ilyas, Resmi Santhakumari Madhusoodhanan, Achu Laila Ashokan, Zinia T Nujum, Sara Varghese, Chinu Jose, Ananth Mohan, Anish Tekkumkara Surendrannair, Mathew J Valamparampil, Rajesh Raghunath, Harikrishnan Muraleedharanpillai, Amjith Rajeevan, Krishna Sulochana Devadhas, Sreekanth Balakrishnan Karthikeyan
Publikováno v:
Asia Pacific Journal of Public Health. 30:351-360
Cardiovascular disease (CVD) is the leading cause of morbidity and mortality in the world. The determinants of CVD in an urban population using conventional and geographic information system techniques were attempted as a community-based census-type
Autor:
Valamparampil MJ; 1 Government Medical College Hospital, Thiruvananthapuram, Kerala, India., Mohan A; 1 Government Medical College Hospital, Thiruvananthapuram, Kerala, India., Jose C; 2 University of Kerala, Thiruvananthapuram, Kerala, India., Sadheesan DK; 1 Government Medical College Hospital, Thiruvananthapuram, Kerala, India., Aby JJ; 1 Government Medical College Hospital, Thiruvananthapuram, Kerala, India., Vasudevakaimal P; 2 University of Kerala, Thiruvananthapuram, Kerala, India., Varghese S; 3 Government Medical College Hospital, Kollam, Kerala, India., Surendrannair AT; 1 Government Medical College Hospital, Thiruvananthapuram, Kerala, India., Ashokan AL; 2 University of Kerala, Thiruvananthapuram, Kerala, India., Madhusoodhanan RS; 4 Directorate of Health Services, Government of Kerala, Palakkad, Kerala, India., Ilyas IS; 1 Government Medical College Hospital, Thiruvananthapuram, Kerala, India., Rajeevan A; 5 Directorate of Health Services, Government of Kerala, Pathanamthitta, Kerala, India., Karthikeyan SB; 1 Government Medical College Hospital, Thiruvananthapuram, Kerala, India., Devadhas KS; 1 Government Medical College Hospital, Thiruvananthapuram, Kerala, India., Raghunath R; 2 University of Kerala, Thiruvananthapuram, Kerala, India., Surendran S; 1 Government Medical College Hospital, Thiruvananthapuram, Kerala, India., Muraleedharanpillai H; 1 Government Medical College Hospital, Thiruvananthapuram, Kerala, India., Nujum ZT; 3 Government Medical College Hospital, Kollam, Kerala, India.
Publikováno v:
Asia-Pacific journal of public health [Asia Pac J Public Health] 2018 May; Vol. 30 (4), pp. 351-360. Date of Electronic Publication: 2018 Apr 12.